202 related articles for article (PubMed ID: 24422538)
1. Combination of amino acid/dipeptide with nitric oxide donating oleanolic acid derivatives as PepT1 targeting antitumor prodrugs.
Fang L; Wang M; Gou S; Liu X; Zhang H; Cao F
J Med Chem; 2014 Feb; 57(3):1116-20. PubMed ID: 24422538
[TBL] [Abstract][Full Text] [Related]
2. Propylene glycol-linked amino acid/dipeptide diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability, and pharmacokinetics.
Cao F; Gao Y; Wang M; Fang L; Ping Q
Mol Pharm; 2013 Apr; 10(4):1378-87. PubMed ID: 23339520
[TBL] [Abstract][Full Text] [Related]
3. Hybrid molecule from O2-(2,4-dinitrophenyl)diazeniumdiolate and oleanolic acid: a glutathione S-transferase π-activated nitric oxide prodrug with selective anti-human hepatocellular carcinoma activity and improved stability.
Fu J; Liu L; Huang Z; Lai Y; Ji H; Peng S; Tian J; Zhang Y
J Med Chem; 2013 Jun; 56(11):4641-55. PubMed ID: 23617697
[TBL] [Abstract][Full Text] [Related]
4. Ethylene glycol-linked amino acid diester prodrugs of oleanolic acid for PepT1-mediated transport: synthesis, intestinal permeability and pharmacokinetics.
Cao F; Jia J; Yin Z; Gao Y; Sha L; Lai Y; Ping Q; Zhang Y
Mol Pharm; 2012 Aug; 9(8):2127-35. PubMed ID: 22352697
[TBL] [Abstract][Full Text] [Related]
5. Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.
Tsume Y; Hilfinger JM; Amidon GL
Mol Pharm; 2008; 5(5):717-27. PubMed ID: 18652477
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of CDDO-amino acid-nitric oxide donor trihybrids as potential antitumor agents against both drug-sensitive and drug-resistant colon cancer.
Ai Y; Kang F; Huang Z; Xue X; Lai Y; Peng S; Tian J; Zhang Y
J Med Chem; 2015 Mar; 58(5):2452-64. PubMed ID: 25675144
[TBL] [Abstract][Full Text] [Related]
7. Dipeptide derivatives of AZT: synthesis, chemical stability, activation in human plasma, hPEPT1 affinity, and antiviral activity.
Santos C; Morais J; Gouveia L; de Clercq E; Pannecouque C; Nielsen CU; Steffansen B; Moreira R; Gomes P
ChemMedChem; 2008 Jun; 3(6):970-8. PubMed ID: 18389514
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-hepatocellular carcinoma activity of novel O
Zou Y; Yan C; Liu JC; Huang ZJ; Xu JY; Zhou JP; Zhang HB; Zhang YH
Chin J Nat Med; 2017 Dec; 15(12):928-937. PubMed ID: 29329650
[TBL] [Abstract][Full Text] [Related]
9. Potential Development of Tumor-Targeted Oral Anti-Cancer Prodrugs: Amino Acid and Dipeptide Monoester Prodrugs of Gemcitabine.
Tsume Y; Drelich AJ; Smith DE; Amidon GL
Molecules; 2017 Aug; 22(8):. PubMed ID: 28796151
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-human hepatocellular carcinoma activity of new nitric oxide-releasing glycosyl derivatives of oleanolic acid.
Huang Z; Zhang Y; Zhao L; Jing Y; Lai Y; Zhang L; Guo Q; Yuan S; Zhang J; Chen L; Peng S; Tian J
Org Biomol Chem; 2010 Feb; 8(3):632-9. PubMed ID: 20090981
[TBL] [Abstract][Full Text] [Related]
11. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole as potential substrates of hPEPT1 transporter.
Song X; Vig BS; Lorenzi PL; Drach JC; Townsend LB; Amidon GL
J Med Chem; 2005 Feb; 48(4):1274-7. PubMed ID: 15715497
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity evaluation of oleanolic acid derivatives.
Hao J; Liu J; Wen X; Sun H
Bioorg Med Chem Lett; 2013 Apr; 23(7):2074-7. PubMed ID: 23434227
[TBL] [Abstract][Full Text] [Related]
13. Nitroreductase-activated nitric oxide (NO) prodrugs.
Sharma K; Sengupta K; Chakrapani H
Bioorg Med Chem Lett; 2013 Nov; 23(21):5964-7. PubMed ID: 24050886
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.
Sidoryk K; Switalska M; Wietrzyk J; Jaromin A; Piętka-Ottlik M; Cmoch P; Zagrodzka J; Szczepek W; Kaczmarek L; Peczyńska-Czoch W
J Med Chem; 2012 Jun; 55(11):5077-87. PubMed ID: 22574992
[TBL] [Abstract][Full Text] [Related]
15. Kinetics and mechanisms of activation of alpha-amino acid ester prodrugs of camptothecins.
Song L; Bevins R; Anderson BD
J Med Chem; 2006 Jul; 49(14):4344-55. PubMed ID: 16821794
[TBL] [Abstract][Full Text] [Related]
16. Diazen-1-ium-1,2-diolated and nitrooxyethyl nitric oxide donor ester prodrugs of anti-inflammatory (E)-2-(aryl)-3-(4-methanesulfonylphenyl)acrylic acids: synthesis, cyclooxygenase inhibition, and nitric oxide release studies.
Abdellatif KR; Chowdhury MA; Dong Y; Chen QH; Knaus EE
Bioorg Med Chem; 2008 Mar; 16(6):3302-8. PubMed ID: 18096394
[TBL] [Abstract][Full Text] [Related]
17. Oleanolic acid-NO donor-platinum(II) trihybrid molecules: Targeting cytotoxicity on hepatoma cells with combined action mode and good safety.
Fang L; Feng M; Chen F; Liu X; Shen H; Zhao J; Gou S
Bioorg Med Chem; 2016 Oct; 24(19):4611-4619. PubMed ID: 27501909
[TBL] [Abstract][Full Text] [Related]
18. Targeted delivery to PEPT1-overexpressing cells: acidic, basic, and secondary floxuridine amino acid ester prodrugs.
Landowski CP; Vig BS; Song X; Amidon GL
Mol Cancer Ther; 2005 Apr; 4(4):659-67. PubMed ID: 15827340
[TBL] [Abstract][Full Text] [Related]
19. Chemical and biological evaluation of dipeptidyl boronic acid proteasome inhibitors for use in prodrugs and pro-soft drugs targeting solid tumors.
Milo LJ; Lai JH; Wu W; Liu Y; Maw H; Li Y; Jin Z; Shu Y; Poplawski SE; Wu Y; Sanford DG; Sudmeier JL; Bachovchin WW
J Med Chem; 2011 Jul; 54(13):4365-77. PubMed ID: 21634429
[TBL] [Abstract][Full Text] [Related]
20. Amino acid ester prodrugs of the anticancer agent gemcitabine: synthesis, bioconversion, metabolic bioevasion, and hPEPT1-mediated transport.
Song X; Lorenzi PL; Landowski CP; Vig BS; Hilfinger JM; Amidon GL
Mol Pharm; 2005; 2(2):157-67. PubMed ID: 15804190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
